Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

1.440 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk ↗

March 28, 2025

Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential milestone payments of up to $1 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 28, 2025

Via Benzinga

What Analysts Are Saying About Lexicon Pharmaceuticals Stock ↗

March 07, 2025

Via Benzinga

Here are the top movers in Monday's session. ↗

March 03, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

January 29, 2025

Via Benzinga

Analyst Expectations For Lexicon Pharmaceuticals's Future ↗

December 23, 2024

Via Benzinga

Demystifying Lexicon Pharmaceuticals: Insights From 10 Analyst Reviews ↗

November 13, 2024

Via Benzinga

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Preview: Lexicon Pharmaceuticals's Earnings ↗

November 11, 2024

Via Benzinga

The Analyst Landscape: 11 Takes On Lexicon Pharmaceuticals ↗

November 05, 2024

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

March 03, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Monday? ↗

March 03, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Lexicon Pharmaceuticals (LXRX) Stock Is Down: What's Going On? ↗

March 03, 2025

Lexicon Pharmaceuticals shares are trading lower by 48% Monday morning. The company earlier announced topline results from its PROGRESS Phase 2b study evaluating pilavapadin.

Via Benzinga

Monday's pre-market session: top gainers and losers ↗

March 03, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagliflozin to Reduce Major Adverse Cardiovascular Events (MACE)

February 18, 2025

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain

January 21, 2025

Event will feature insights on LX9211, Lexicon’s novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on DPNP

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon Appoints Scott Coiante as Chief Financial Officer

January 02, 2025

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)

December 20, 2024

Confirms Previously Disclosed and Anticipated FDA Decision

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

2 Generic Drug Stocks Ready to Surge in 2025

November 27, 2024

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

Via MarketBeat

Topics Government Intellectual Property

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

November 26, 2024

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon Pharmaceuticals to Participate in December Investor Conferences

November 25, 2024

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA

November 22, 2024

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon Appoints Ivan H. Cheung to Board of Directors

November 20, 2024

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

What You Missed On Wall Street This Past Friday ↗

November 03, 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

Crude Oil Moves Higher; Apple Shares Slide After Q4 Results ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results ↗

November 01, 2024

Via Benzinga

Dow Jumps 400 Points; US Adds 12,000 Jobs In October ↗

November 01, 2024

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.